The Oncology Journal Club Episode 17: Cardio Oncology Special

Pinterest LinkedIn Tumblr +

This week we have a Special Episode of The Oncology Journal Club focused on Cardio Oncology.

Eva Segelov talks to Professor Steve Nicholls about the newly opened Victorian Heart Hospital and discusses key papers to bring you up to date on all things Cardio Oncology, perfect timing as this was a focus of the recent COSA ASM.

Craig Underhill gives us some snappy Quick Bites and Hans Prenen is back with a COVID-19 update from Belgium where he’s been working in very challenging circumstances, so this is an insightful European perspective on the ongoing global pandemic.

With the usual top quality banter, papers you won’t hear anywhere else and expert analysis from our Hosts, you are in for another great episode of The Oncology Journal Club!

…And we urge you to keep listening to the very end for a sneak preview of what to expect from our next episode (earworm warning!)

About The Oncology Journal Club:

We have taken an old concept and updated it with a new format. In each episode a team of expert contributors will review topical journal papers and interview special guests who are leaders in their fields to help keep you informed of the latest developments on the go.

With The Oncology Podcast – and The Oncology Journal Club in particular – we are aiming to deliver oncology news differently,” Rachael Babin, Editor-in-Chief, Oncology News.

The Oncology Journal Club is hosted by Professor Eva Segelov, from Monash University. Eva is joined by Dr Craig Underhill from Albury-Wodonga and Professor Hans Prenen from Antwerp, Belgium. We hope you enjoy listening and find this a valuable and entertaining resource.

This Week’s Papers:

  1. Segelov, E., et al. Practical Considerations for Treating Patients With Cancer in the COVID-19 Pandemic. JCO Oncology Practice 16, no. 8 (August 01, 2020) 467-482. Published online May 13, 2020. Access online here.
  2. Alexandre, Joachim, et al. Cardiovascular Toxicity Related to Cancer Treatment: A Pragmatic Approach to the American and European Cardio-Oncology Guidelines. Journal of the American Heart Association. 2020;9:e018403. DOI: 10.1161/JAHA.120.018403. Access online here.
  3. Seton-Rogers, S. Cardiovascular disease and cancer communicate. Nat Rev Cancer (2020).
  4. Koelwyn, G.J., et al. Myocardial infarction accelerates breast cancer via innate immune reprogramming. Nat Med (2020). Access online here.
  5. Conduit, C., et al. Real-world impact of anti-HER2 therapy-related cardiotoxicity in patients with advanced HER2-positive breast cancer. Asia-Pac J Clin Oncol. 2020; 1– 7. Access online here.

Quick Bites:

  1. Prasad, P., et al. Cardio-Oncology Preventive Care: Racial and Ethnic Disparities. Curr Cardiovasc Risk Rep 14, 18 (2020). Access online here.
  2. Ananthan, K., et al. The Role of Biomarkers in Cardio-Oncology. Journal of cardiovascular translational research 13,3 (2020): 431-450. doi:10.1007/s12265-020-10042-3 Access online here.
  3. Zhang, Y., et al. Cardio-Oncology in China: We Are on the Go! J Am Coll Cardiol CardioOnc. 2020 Mar, 2 (1) 139–143. Access online here.
  4. Brown SA., et al. Leveraging Social Media for Cardio-Oncology. Curr Treat Options Oncol. 2020 Aug 13;21(10):83. doi: 10.1007/s11864-020-00775-3. PMID: 32789716. Access online here
  5. Lenihan, D., et al. Cardio‐oncology care in the era of the coronavirus disease 2019 (COVID‐19) pandemic: An International Cardio‐Oncology Society (ICOS) statement. CA CANCER J CLIN 2020. Access online here.

This Week’s Team:

Professor Eva Segelov

Eva Segelov

Professor Eva Segelov is a Medical Oncologist and is Director of Oncology at Monash University and Monash Health, Melbourne, Victoria, previously Senior Medical Oncologist at St Vincent’s Hospital, St Vincent’s Private Hospital and St Vincent’s Clinic and Associate Professor of Medicine, University of New South Wales.

Eva has an interest in academic clinical trials in GI and breast cancer and has been a member of the AGITG since 2003. She has clinical trials expertise, links with national and international trials groups, and extensive experience with adult medical education.


Professor Hans Prenen

Hans Prenen

Professor Hans Prenen is a medical oncologist and head of the phase 1 – early clinical trials unit at the Antwerp University Hospital in Belgium. He is a member of several scientific organisations, published many scientific oncology papers in prestigious journals and is regularly invited for lectures at national and international meetings.  His interests are clinical trials and translational research with a focus on digestive oncology.



Dr Craig Underhill

Craig Underhill

Dr Craig Underhill completed his Bachelor of Medicine and Surgery in 1987 at Melbourne University. He completed medical oncology training in Melbourne and worked as the Senior Clinical Research Registrar at Guy’s Hospital, London.

In 1998 arrived in Albury-Wodonga and established a medical oncology practice and clinical trials unit which has developed expertise and infrastructure to ensure the initiation of high quality trials. The research Unit lead by Dr Underhill has twice been awarded NSW Premier’s Award for Innovation in Cancer Clinical Trials, the inaugural award in 2009 and then again in 2012.

Dr Underhill chaired a working party that was instrumental in securing $65 million in federal funding for The Albury Wodonga Regional Cancer Centre which opened in September 2016.

Dr Underhill is the VCCC Regional Oncology Lead and advocates for the increased access to clinical trials for regional Victorians and leads the VCCC teletrials program.

Steve Nicholls

Steve Nicholls

Steve Nicholls is the Director of MonashHeart, Director of Victorian Heart Institute and Professor of Cardiology at Monash University. He is now Director of the Victorian Heart Hospital. He completed his cardiology training at John Hunter Hospital and PhD at the University of Adelaide, prior to holding a postdoctoral fellowship and faculty appointment at the Cleveland Clinic and the South Australian Health and Medical Research Institute.

His research interests focus on the role of metabolic risk factors and imaging in atherosclerosis, with work spanning from early discovery to leadership of large clinical trials. He is Chair of the Australian Atherosclerosis Society Clinical Council, Australia and New Zealand Alliance for Cardiovascular Trials, Asia Pacific Cardiometabolic Consortium, Secretary of the Cardiac Society of Australia and New Zealand and a Fellow of the Australian Academy of Health and Medical Sciences.

Rachael Babin

Rachael Babin

Rachael Babin is Editor-in-Chief of The Oncology Newsletter and Publisher of For regular oncology updates for healthcare professionals, please subscribe to The Oncology Newsletter.

With thanks to Eva Segelov, Craig Underhill, Hans Prenen, Steve Nicholls and Graham Knowles.


About Author

The ONA Editor curates oncology news, views and reviews from Australia and around the world for our readers. In aggregated content, original sources will be acknowledged in the article footer.

Leave A Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.